it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..

gelfand noted the impact on hdl may be balanced by the improvement seen in markers of.

biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.